VectivBio raises 125 million US dollars in stock sale VectivBio has announced the closing of the subscription offer for 16,700,000 ordinary shares. The Basel-based biotechnology firm has generated gross…martin10.21.2022
KetoSwiss secures capital increase of 4 million dollars KetoSwiss has banked a total of 4 million US dollars from investors. The Basel-based startup develops products to alleviate neurological…martin10.14.2022
Escientia Switzerland becomes Primopus The Indian company Deccan Fine Chemicals is acquiring Escientia Switzerland and renaming it as Primopus AG. The new owner announces…martin10.13.2022
Novartis investing 100 million Swiss francs in new biologics center The pharmaceutical company Novartis is investing a sum of 100 million Swiss francs in a new competence center for biologics…martin09.12.2022
Official opening of the competence center uptownBasel uptownBasel celebrated its official opening. Technology companies such as Bouygues and Vinci Energies are already occupying the first building of…martin09.09.2022
Roche opens tallest building in Switzerland Roche has inaugurated a new office building with 3,200 positions in Basel. Standing 205 meters high, Building 2 is the…martin09.05.2022
DelphianLogic opens European headquarters in Basel DelphianLogic has opted for Basel as the location for its European headquarters. From its new base in Basel, the award-winning…annett08.18.2022
Forty51 closes first fund totaling 43 million US dollars A new Basel-based venture fund, Forty51 Ventures I, has raised a total of 43 million US dollars following a first…annett07.19.2022
Basel Area achieves milestone with settling of LifeMine Life sciences company LifeMine Therapeutics from the USA has established its European headquarters in the Basel Area. With this, Basel…martin07.06.2022
Space Pharmaceuticals establishes presence in Basel Space Pharmaceuticals AG is strengthening the life sciences cluster in the Basel Area. At its research lab, the cheminformatics company…martin07.01.2022